India will begin its COVID-19 vaccination drive on Saturday.
New Delhi:
Ahead of the COVID-19 vaccination drive that begins Saturday, Union Health Minister Harsh Vardhan took to Twitter on Thursday, to dispel doubts concerning the vaccines.
Posting a collection of graphics on Twitter, the minister addressed fears just like the vaccine inflicting infertility or spreading the coronavirus an infection.
“There is no scientific evidence to suggest that #COVIDVaccine could cause infertility in either men or women. Kindly do not pay heed to such rumours or information from unverified sources,” he mentioned in a single tweet.
“You cannot contract #COVID19 because you have been inoculated with a #COVID19Vaccine Temporary side effects such as mild fever should not be confused as having contracted #COVID,” the minister mentioned in one other.
After being administered #COVID19Vaccine, some people might have unintended effects like gentle fever, ache at injection website & bodyache. This is just like the unintended effects that happen put up another vaccines.
These are anticipated to go away on their very own after a while. #StaySafepic.twitter.com/VCnJzXu70S
— Dr Harsh Vardhan (@drharshvardhan) January 14, 2021
You can’t contract #COVID19 as a result of you’ve gotten been inoculated with a #COVID19Vaccine
Temporary unintended effects comparable to gentle fever shouldn’t be confused as having contracted #COVID.#StayInformedStaySafe@PMOIndia@MoHFW_INDIApic.twitter.com/ZkZgLU8tpy
— Dr Harsh Vardhan (@drharshvardhan) January 14, 2021
There isn’t any scientific proof to recommend that #COVIDVaccine might trigger infertility in both males or ladies. Kindly don’t pay heed to such rumours or info from unverified sources.#StayInformedStaySafe@PMOIndia@MoHFW_INDIApic.twitter.com/6ii2EFgpB0
— Dr Harsh Vardhan (@drharshvardhan) January 14, 2021
The authorities on Saturday will launch what it says is the world’s greatest vaccination programme with photographs manufactured in India – one developed by Oxford University and pharma big AstraZeneca, the opposite by Bharat Biotech International and India’s high medical analysis physique.
Authorities will deal with the home COVID-19 vaccine “equally” with the outstanding international one, though the homegrown drug’s efficacy has not been confirmed, and other people may have no alternative which they one they get, authorities officers have hinted.
Administering Bharat Biotech’s Covaxin, a transfer cheered by politicians has fearful some well being specialists who contemplate it rushed, because the vaccine has solely restricted, “clinical-trial mode” approval and has not accomplished Phase three trials when its efficacy is measured.
Experts at India’s drug regulator this month advisable stricter monitoring for Covaxin, as is finished throughout medical trials, particularly if circumstances of an infection by mutant strains of the virus unfold quick. At the identical time, the federal government needs to inoculate as many individuals as potential as demand for vaccines outstrips provide.
Health advocacy teams, watchdogs and opposition politicians have questioned the vaccine’s approval, which got here only a day after the authorities requested Hyderabad-based Bharat Biotech for extra proof it could work.
(With inputs from companies)
Be First to Comment